Introducing Hyperthermic Intraperitoneal Chemotherapy into Gynecological Oncology Practice - Feasibility and Safety Considerations: Single-Center Experience

被引:2
作者
Abramian, Alina [1 ]
Zivanovic, Oliver [1 ,2 ]
Kuhn, Walther [1 ]
Weber, Stefan [3 ]
Schaefer, Nico [4 ]
Keyver-Paik, Mignon-Denise [1 ]
Kiefer, Nicholas [3 ]
机构
[1] Univ Hosp Bonn, Ctr Integrated Oncol, Dept Obstet & Gynecol, Sigmund Freud Str 25, D-53105 Bonn, Germany
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, 1275 York Ave, New York, NY 10021 USA
[3] Univ Hosp Bonn, Ctr Integrated Oncol, Dept Anesthesiol, Bonn, Germany
[4] Univ Hosp Bonn, Ctr Integrated Oncol, Dept Surg, Bonn, Germany
关键词
HIPEC; Cisplatin; Hyperthermic intraoperative intraperitoneal chemoperfusion; Ovarian cancer; Gynecological oncology practice; EPITHELIAL OVARIAN-CANCER; PHASE-II TRIAL; CYTOREDUCTIVE SURGERY; PERITONEAL CARCINOMATOSIS; NEOADJUVANT CHEMOTHERAPY; EPIDURAL ANALGESIA; SYSTEMIC CHEMOTHERAPY; THERMAL ENHANCEMENT; COLORECTAL-CANCER; RANDOMIZED-TRIAL;
D O I
10.1159/000445180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Within the surgical oncology community interest is increasingly focusing on combining surgical cytoreduction and regional chemotherapeutic drug delivery to manage solid abdominal tumors. In particular, the role of hyperthermic intraperitoneal chemotherapy (HIPEC) is evolving for treating epithelial ovarian carcinomas (EOCs), as EOCs remain confined to the peritoneal cavity for most of their natural history. Currently there is no evidence from prospective trials to confirm an overall survival benefit associated with HIPEC. In addition, there are no generally accepted regimens, which results in heterogeneous clinical procedures. Methods: We have initiated a HIPEC program at our institution and completed a phase I study of HIPEC with cisplatin in patients with platinum-sensitive recurrent EOC. The data have been published and prove the feasibility of this approach. In the process of introducing HIPEC, several safety measures had to be taken into consideration. Results: We present the implications and requirements of introducing HIPEC in clinical practice and discuss our proposed procedure referring to the recent literature. Conclusion: HIPEC is feasible and can be performed safely in daily gynecological oncology routine provided that certain considerations and precautions are taken into account during its introduction to guarantee a proper and safe operating sequence. (C) 2016 S. Karger GmbH, Freiburg
引用
收藏
页码:178 / 184
页数:7
相关论文
共 48 条
[1]  
ALBERTS DS, 1980, JNCI-J NATL CANCER I, V65, P455
[2]  
[Anonymous], AM J OBSTET GYNECOLO
[3]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[4]   Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer [J].
Bakrin, N. ;
Classe, J. M. ;
Pomel, C. ;
Gouy, S. ;
Chene, G. ;
Glehen, O. .
JOURNAL OF VISCERAL SURGERY, 2014, 151 (05) :347-353
[5]   Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer [J].
Bijelic, L. ;
Jonson, A. ;
Sugarbaker, P. H. .
ANNALS OF ONCOLOGY, 2007, 18 (12) :1943-1950
[6]   Anesthetic technique for radical prostatectomy surgery affects cancer recurrence - A retrospective analysis [J].
Biki, Barbara ;
Mascha, Edward ;
Moriarty, Denis C. ;
Fitzpatrick, John M. ;
Sessler, Daniel I. ;
Buggy, Donal J. .
ANESTHESIOLOGY, 2008, 109 (02) :180-187
[7]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[8]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[9]   A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin [J].
Cao, Christopher ;
Yan, Tristan D. ;
Black, Deborah ;
Morris, David L. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (08) :2152-2165
[10]  
Clemente A, 2008, MINERVA ANESTESIOL, V74, P549